Planned phase IIb trial of ciclosporin for moderate to severe traumatic brain injuries.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Brain injuries
- Focus Proof of concept; Registrational; Therapeutic Use
- Sponsors NeuroVive Pharmaceutical
- 21 Sep 2017 According to a NeuroVive Pharmaceutical AB media release, the EMA Scientific Advice feedback is supportive of the novel design of this trial.
- 07 Apr 2014 New trial record